Literature DB >> 21394825

IDUA mutational profiling of a cohort of 102 European patients with mucopolysaccharidosis type I: identification and characterization of 35 novel α-L-iduronidase (IDUA) alleles.

Francesca Bertola1, Mirella Filocamo, Giorgio Casati, Matthew Mort, Camillo Rosano, Anna Tylki-Szymanska, Beyhan Tüysüz, Orazio Gabrielli, Serena Grossi, Maurizio Scarpa, Giancarlo Parenti, Daniela Antuzzi, Jaime Dalmau, Maja Di Rocco, Carlo Dionisi Vici, Ilyas Okur, Jordi Rosell, Attilio Rovelli, Francesca Furlan, Miriam Rigoldi, Andrea Biondi, David N Cooper, Rossella Parini.   

Abstract

Mutational analysis of the IDUA gene was performed in a cohort of 102 European patients with mucopolysaccharidosis type I. A total of 54 distinct mutant IDUA alleles were identified, 34 of which were novel including 12 missense mutations, 2 nonsense mutations, 12 splicing mutations, 5 micro-deletions, 1 micro-duplication 1 translational initiation site mutation, and 1 'no-stop' change (p.X654RextX62). Evidence for the pathological significance of all novel mutations identified was sought by means of a range of methodological approaches, including the assessment of evolutionary conservation, RT-PCR/in vitro splicing analysis, MutPred analysis and visual inspection of the 3D-model of the IDUA protein. Taken together, these data not only demonstrate the remarkable mutational heterogeneity characterizing type 1 mucopolysaccharidosis but also illustrate our increasing ability to make deductions pertaining to the genotype-phenotype relationship in disorders manifesting a high degree of allelic heterogeneity.
© 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21394825     DOI: 10.1002/humu.21479

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  25 in total

1.  Genetic testing of Mucopolysaccharidoses disease using multiplex PCR- based panels of STR markers: in silico analysis of novel mutations.

Authors:  Mehdi Shafaat; Mehrdad Hashemi; Ahmad Majd; Maryam Abiri; Sirous Zeinali
Journal:  Metab Brain Dis       Date:  2019-06-24       Impact factor: 3.584

Review 2.  Lysosomal storage disease overview.

Authors:  Angela Sun
Journal:  Ann Transl Med       Date:  2018-12

3.  Epidemiology of mucopolysaccharidoses.

Authors:  Shaukat A Khan; Hira Peracha; Diana Ballhausen; Alfred Wiesbauer; Marianne Rohrbach; Matthias Gautschi; Robert W Mason; Roberto Giugliani; Yasuyuki Suzuki; Kenji E Orii; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2017-05-26       Impact factor: 4.797

4.  Human α-L-iduronidase uses its own N-glycan as a substrate-binding and catalytic module.

Authors:  Nobuo Maita; Takahiro Tsukimura; Takako Taniguchi; Seiji Saito; Kazuki Ohno; Hisaaki Taniguchi; Hitoshi Sakuraba
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

5.  A Novel Frameshift Mutation Associated with Hurler's Syndrome: A Case Report.

Authors:  Mana Kamranjam; Seyedeh Maryam Hosseini; Mohammadreza Alaei
Journal:  J Pediatr Genet       Date:  2019-04-03

6.  Mucopolysaccharidosis (MPS) Physical Symptom Score: Development, Reliability, and Validity.

Authors:  A Ahmed; K Rudser; A Kunin-Batson; K Delaney; C Whitley; E Shapiro
Journal:  JIMD Rep       Date:  2015-08-25

7.  Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure.

Authors:  Minke H de Ru; Jaap J Boelens; Anibh M Das; Simon A Jones; Johanna H van der Lee; Nizar Mahlaoui; Eugen Mengel; Martin Offringa; Anne O'Meara; Rossella Parini; Attilio Rovelli; Karl-Walter Sykora; Vassili Valayannopoulos; Ashok Vellodi; Robert F Wynn; Frits A Wijburg
Journal:  Orphanet J Rare Dis       Date:  2011-08-10       Impact factor: 4.123

8.  Capturing phenotypic heterogeneity in MPS I: results of an international consensus procedure.

Authors:  Minke H de Ru; Quirine Ga Teunissen; Johanna H van der Lee; Michael Beck; Olaf A Bodamer; Lorne A Clarke; Carla E Hollak; Shuan-Pei Lin; Maria-Verónica Muñoz Rojas; Gregory M Pastores; Julian A Raiman; Maurizio Scarpa; Eileen P Treacy; Anna Tylki-Szymanska; J Edmond Wraith; Jiri Zeman; Frits A Wijburg
Journal:  Orphanet J Rare Dis       Date:  2012-04-23       Impact factor: 4.123

9.  An algorithm to predict phenotypic severity in mucopolysaccharidosis type I in the first month of life.

Authors:  Sandra D K Kingma; Eveline J Langereis; Clasine M de Klerk; Lida Zoetekouw; Tom Wagemans; Lodewijk IJlst; Ronald J A Wanders; Frits A Wijburg; Naomi van Vlies
Journal:  Orphanet J Rare Dis       Date:  2013-07-09       Impact factor: 4.123

10.  Clinical and Molecular Characterization of Patients with Mucopolysaccharidosis Type I in an Algerian Series.

Authors:  Abdellah Tebani; Lahouaria Zanoutene-Cheriet; Zoubir Adjtoutah; Lenaig Abily-Donval; Carole Brasse-Lagnel; Annie Laquerrière; Stephane Marret; Abla Chalabi Benabdellah; Soumeya Bekri
Journal:  Int J Mol Sci       Date:  2016-05-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.